To elaborate on the molecular mechanisms of circRNA-mediated ferroptosis-immunity crosstalk in cancer and explore their potential as diagnostic biomarkers and therapeutic targets, emphasizing their implications for precision medicine.
Approach:
Key Findings:
CircRNAs are involved in regulating tumor progression through multiple mechanisms, including miRNA sponging and protein interactions.
Ferroptosis and anti-tumor immunity are interconnected, with ferroptotic cells activating immune responses and immune cells influencing ferroptosis susceptibility.
CircRNAs can simultaneously target key nodes in ferroptosis and immune pathways, representing a novel regulatory concept termed 'dual regulation'.
Interpretation:
CircRNAs play a critical role in linking ferroptosis and immune responses in cancer, providing insights into potential therapeutic strategies.
Limitations:
The review primarily focuses on the molecular mechanisms without extensive clinical validation of circRNAs as biomarkers or therapeutic targets, highlighting the need for more empirical studies.
Further research is needed to fully understand the complex interactions and regulatory networks involving circRNAs in cancer, particularly in clinical settings.
Conclusion:
CircRNAs represent promising candidates for precision cancer therapy by targeting both ferroptosis and immune pathways, underscoring the significance of their dual regulatory roles.
